"Every year, TechCrunch's Startup Battlefield pitch contest draws thousands of applicants. We whittle those applications down to the top 200 contenders, and of them, the top 20 compete on the big stage to become the winner, taking home the Startup Battlefield Cup and a cash prize of $100,000. But the remaining 180 startups all blew us away as well in their respective categories and compete in their own pitch competition."
"What it does: CasNx has invented a new kind of antivirus treatment for organs from organ donors. Why it's noteworthy: The startup has invented a gene-editing CRISPR kit that eliminates viruses and installs "universal donor" markers while the organ is being preserved outside the body. What it does: Chipiron is building a light and inexpensive, open full-body MRI machine intended to make MRI cancer diagnostics more widely available."
Two hundred biotech and pharma startups were selected for the Startup Battlefield cohort, with 20 finalists on the main stage and 180 competing in the broader pitch competition. CasNx developed a CRISPR-based antiviral kit that eliminates viruses and installs "universal donor" markers during organ preservation. Chipiron is building an inexpensive, open full-body MRI using SQUID magnetometer technology to expand MRI cancer diagnostics access. Exactics is creating a platform for rapid consumer diagnostic tests, starting with at-home Lyme disease screening. Lumos offers a high-frequency electromagnetic device for inductive therapy. Miraqules developed a powder nanotechnology that mimics clotting proteins to provide instant blood clotting.
Read at TechCrunch
Unable to calculate read time
Collection
[
|
...
]